Australia should develop local screening guidelines for hydroxychloroquine retinopathy given the number of rheumatology patients using the DMARD long term and at risk of permanent vision loss. A Perspective article in the MJA said thousands of Australians were potentially at risk given a 7.5% prevalence rate of retinopathy in patients who had taken hydroxychloroquine (HCQ) ...
Call for consensus on HCQ retinopathy screening
By Mardi Chapman
31 Mar 2021